0.00Open0.75Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV0.74%PremiumAug 16, 2024Expiry Date0.70Intrinsic Value100Multiplier-7DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma9.07Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Voyager Therapeutics Stock Discussion
Voyager Therapeutics Says First Participants Dosed In Single Ascending Dose Trial of VY-TAU01 For Treatment Of Alzheimer's Disease
No comment yet